Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Sonodynamic therapy (SDT) is a noninvasive cancer treatment using ultrasound to activate sonosensitizers, generating reactive oxygen species (ROS).
• SDT offers advantages over photodynamic therapy, including deeper tissue penetration and reduced side effects.
• Limitations of SDT necessitate advancements, particularly through nanotechnology integration.

Purpose of the Study:

• To review nanomaterial-assisted combinational sonodynamic cancer therapy.
• To highlight design principles for synergistic therapeutic effects using nanomaterials.
• To provide insights for future clinical translation of SDT.

Main Methods:

• Literature review focusing on nanomaterial applications in SDT.
• Analysis of design strategies for synergistic effects in combined therapies.
• Discussion of engineering principles for nanomaterial-based SDT.

Main Results:

• Nanotechnology facilitates the development of novel platforms to overcome SDT limitations.
• Combinational SDT strategies, particularly those enhanced by nanomaterials, show superior anticancer efficacy compared to monotherapies.
• Engineering nanomaterials is key to achieving synergistic effects in SDT.

Conclusions:

• Nanomaterial-based SDT holds significant potential for enhanced cancer treatment.
• Further research into nanomaterial design can optimize synergistic effects for improved clinical outcomes.
• This review stimulates innovation in combined sonodynamic therapy for future clinical applications.